Pancreatic progenitor epigenome maps prioritize type 2 diabetes risk genes with roles in development.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33544077.
- Also identified by DOI 10.7554/eLife.59067 and PMC identifier 7864636.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Genetic variants associated with type 2 diabetes (T2D) risk affect gene regulation in metabolically relevant tissues, such as pancreatic islets. Here, we investigated contributions of regulatory programs active during pancreatic development to T2D risk. Generation of chromatin maps from developmental precursors throughout pancreatic differentiation of human embryonic stem cells (hESCs) identifies enrichment of T2D variants in pancreatic progenitor-specific stretch enhancers that are not active in islets. Genes associated with progenitor-specific stretch enhancers are predicted to regulate developmental processes, most notably tissue morphogenesis. Through gene editing in hESCs, we demonstrate that progenitor-specific enhancers harboring T2D-associated variants regulate cell polarity genes <i>LAMA1</i> and <i>CRB2</i>. Knockdown of <i>lama1</i> or <i>crb2</i> in zebrafish embryos causes a defect in pancreas morphogenesis and impairs islet cell development. Together, our findings reveal that a subset of T2D risk variants specifically affects pancreatic developmental programs, suggesting that dysregulation of developmental processes can predispose to T2D.
Medical subject headings
- Diabetes Mellitus, Type 2
- Epigenome
- Intracellular Signaling Peptides and Proteins
- Transcription Factors
- Zebrafish
- Zebrafish Proteins